Journal of Pathology Clinical Research

Papers
(The TQCC of Journal of Pathology Clinical Research is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Contribution of tumour and immune cells to PD‐L1 expression as a predictive biomarker in metastatic triple‐negative breast cancer: exploratory analysis from KEYNOTE‐11933
Issue Information30
Issue Information28
26
Issue Information25
A novel telomere biology disease‐associated gastritis identified through a whole exome sequencing‐driven approach24
NTRK gene aberrations in triple‐negative breast cancer: detection challenges using IHC, FISH, RT‐PCR, and NGS23
Issue Information22
Tumor‐associated macrophages and risk of recurrence in stage III colorectal cancer21
PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer21
Issue Information21
CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways20
Assessment of clinical trial protocols for pathology content using the SPIRIT‐Path guidelines highlights areas for improvement20
The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patients19
More than just acral melanoma: the controversies of defining the disease19
The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple‐negative breast cancers18
VEGFA gene variants are associated with breast cancer progression18
A distinct repertoire of cancer‐associated fibroblasts is enriched in cribriform prostate cancer17
Quick Annotator: an open‐source digital pathology based rapid image annotation tool17
Characterizing the tumor microenvironment in rare renal cancer histological types15
Digital image analysis allows objective stratification of patients with silent PIT1‐lineage pituitary neuroendocrine tumors15
Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes15
Immune checkpoint CD161/LLT1‐associated immunological landscape and diagnostic value in oral squamous cell carcinoma14
Correlation of PD‐L1 expression with CD8+ T cells and oxidative stress‐related molecules NRF2 and NQO1 in esophageal squamous cell carcinoma14
14
Exosome‐derived ANXA9 functions as an oncogene in breast cancer13
Tumor‐associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer13
Exploring prognostic biomarkers in pathological images of colorectal cancer patients via deep learning12
Deep learning‐based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images12
Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases12
Large language models as a diagnostic support tool in neuropathology12
11
11
Identification and validation of NFIA as a novel prognostic marker in renal cell carcinoma11
High cyclin E1 protein, but not gene amplification, is prognostic for basal‐like breast cancer11
Breast cancer survival prediction using an automated mitosis detection pipeline11
Issue Information10
10
Optimization of deep learning models for the prediction of gene mutations using unsupervised clustering9
Identification and therapeutic evaluation of ALK rearrangements in non‐small‐cell lung cancer9
A robust model training strategy using hard negative mining in a weakly labeled dataset for lymphatic invasion in gastric cancer9
Paediatric BCOR‐associated sarcomas with a novel long spliced internal tandem duplication of BCOR exon 159
Follow‐up of intraocular retinoblastoma through the quantitative analysis of conserved nuclear DNA sequences in aqueous humor from patients9
Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements8
First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma8
8
Genome‐wide analysis of mRNA and microRNA expression in colorectal cancer and adjacent normal mucosa8
8
Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer7
Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations7
Transcription start site‐level expression of thyroid transcription factor 1 isoforms in lung adenocarcinoma and its clinicopathological significance7
Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta‐aggregation6
Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real‐world clinical tumor sequencing study6
Issue Information6
Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors6
Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma6
KRT81 and HNF1A expression in pancreatic ductal adenocarcinoma: investigation of predictive and prognostic value of immunohistochemistry‐based subtyping6
Issue Information6
Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry6
0.049893856048584